Neutra Corp. (NTRR)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 16, 2026, 9:30 AM EST
Neutra Revenue
Neutra had revenue of $32.38K in the quarter ending April 30, 2024, with 454.18% growth. This brings the company's revenue in the last twelve months to $66.07K, up 2.95% year-over-year. In the fiscal year ending January 31, 2024, Neutra had annual revenue of $39.53K, down -41.86%.
Revenue (ttm)
66.07K
Revenue Growth
+2.95%
P/S Ratio
9.21
Revenue / Employee
4.40K
Employees
15
Market Cap
608.58K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2024 | 39.53K | -28.46K | -41.86% |
| Jan 31, 2023 | 68.00K | -24.02K | -26.10% |
| Jan 31, 2022 | 92.01K | 82.33K | 849.87% |
| Jan 31, 2021 | 9.69K | 3.29K | 51.48% |
| Jan 31, 2020 | 6.40K | - | - |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
Neutra News
- 2 years ago - Neutra Reflects on 2023 and Looks Forward to 2024 - GlobeNewsWire
- 2 years ago - Neutra Announces Strategic and Financial Value Creation Plan - GlobeNewsWire
- 2 years ago - Neutra Nearing Expansion Into Growing Health, Wellness and Life Sciences Sector - GlobeNewsWire
- 3 years ago - Neutra's Strategic Move to Put the Organization in Position to Achieve Its Plans for Growth - GlobeNewsWire
- 3 years ago - Neutra Executes LOI to Acquire Private Clinical Research Site Management Organization - GlobeNewsWire
- 3 years ago - VIVIS Ready to Launch New Topical As Neutra Eyes Potential Health and Wellness Sector Move - Accesswire
- 3 years ago - Neutra Thanks Seed Investor, Readies for Strong Second-Half Growth - Accesswire
- 4 years ago - Deity's Improved eCommerce Site Now Online; New Product Offering to Soon Follow - Accesswire